|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| C12P 19/34 | |||
| C12N 15/63 | |||
| C12N 15/88 | |||
| C07H 21/02 | |||
| C07H 21/04 | |||
| A01N 43/04 |
| (11) | Number of the document | 1799859 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05798891.7 |
| Date of filing the European patent application | 2005-09-19 | |
| (97) | Date of publication of the European application | 2007-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/033837 |
| Date | 2005-09-19 |
| (87) | Number | WO 2006/034348 |
| Date | 2006-03-30 |
| (30) | Number | Date | Country code |
| 611100 P | 2004-09-17 | US | |
| 663442 P | 2005-03-18 | US |
| (72) |
MONIA, Brett, P., US
SIWKOWSKI, Andrew, M., US
BHANOT, Sanjay, US
|
| (73) |
Isis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | ENHANCED ANTISENSE OLIGONUCLEOTIDES |
| ENHANCED ANTISENSE OLIGONUCLEOTIDES |